| Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 93.23 mm | 93.23 mm | 93.23 mm | 93.23 mm | 93.23 mm | 93.23 mm |
| Cash burn (monthly) | 25.54 mm | 12.86 mm | 6.48 mm | 4.79 mm | 5.67 k | 1.41 mm |
| Cash used (since last report) | 1.05 bn | 528.49 mm | 266.36 mm | 196.76 mm | 232.80 k | 57.97 mm |
| Cash remaining | -955.89 mm | -435.27 mm | -173.13 mm | -103.53 mm | 92.99 mm | 35.25 mm |
| Runway (months of cash) | -37.4 | -33.8 | -26.7 | -21.6 | 16410.7 | 25.0 |
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 99.54 mm |
| Total shares | 10.63 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Growth Equity Opportunities V | 6.59 mm | $40.11 mm |
| Venrock Healthcare Capital Partners III | 4.04 mm | $59.43 mm |
